The effect of 7-Keto Naturalean™ on weight loss:: A randomized, double-blind, placebo-controlled trial

被引:12
作者
Zenk, JL
Helmer, TR
Kassen, LJ
Kuskowski, MA
机构
[1] Minnesota Appl Res Ctr, Chanhassen, MN 55317 USA
[2] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA
来源
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 2002年 / 63卷 / 04期
关键词
weight loss; 7-oxo-DHEA; dehydroepiandrosterone; obesity;
D O I
10.1016/S0011-393X(02)80031-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: A natural metabolite of dehydroepiandrosterone (DHEA), 3-acetyl-7-oxo-dehydroepiandrosterone (7-oxo-DHEA), has been shown to be effective in enhancing weight loss when combined with a diet and exercise program. Objective: This study assessed the effects of a formula containing 7-oxo-DHEA, L-tyrosine, asparagus root extract, choline bitartrate, inositol, copper gluconate, manganese, and potassium iodide (7-Keto Naturalean(TM)) on weight loss, body composition, and basal metabolic rate (BMR) in overweight patients following a weight-reduction diet and exercise regimen. Methods: In this prospective, randomized, double-blind, placebo-controlled trial, healthy, overweight adults were given 7-Keto Naturalean (200 mg/d) or a placebo of maltodextrin and followed a calorie-restricted diet (105 kJ/kg) and an exercise program for 8 weeks. Body weight, body composition (by bioelectric impedance), and BMR (by indirect calorimetry) were measured at baseline, week 4, and week 8. A thyroid panel was done at baseline and week 8. Results: Of 35 healthy, overweight adults enrolled, 33 completed the study (12 men, 21 women; age, 40-69 years; body mass index [BMI], 27.0-42.7 kg/m(2)). Patients taking 7-Keto Naturalean lost significantly more weight after 8 weeks than those taking placebo (mean +/- SD loss, 2.15 +/- 2.38 kg and 0.72 +/- 2.12 kg, respectively) (P = 0.038). The change in BMI in the 7-Keto Naturalean-treated group was significant compared with the change in the placebo group (mean +/- SD decrease, 0.71 +/- 0.79 kg/m(2) and 0.01 +/- 1.05 kg/m(2), respectively) (P = 0.036). There were no other statistically significant differences in any of the other measured variables. 7-Keto Naturalean was well tolerated, and there were no significant adverse events. Conclusion: In this select population, 7-Keto Naturalean combined with a reduced-calorie diet and an exercise program resulted in a significant weight loss compared with diet and exercise alone.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 50 条
  • [21] The Effect of Dietary Supplements Containing Green Tea, Capsaicin and Ginger Extracts on Weight Loss and Metabolic Profiles in Overweight Women: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Taghizadeh, Mohsen
    Farzin, Narjes
    Taheri, Sara
    Mahlouji, Mahnaz
    Akbari, Hossein
    Karamali, Fatemeh
    Asemi, Zatollah
    ANNALS OF NUTRITION AND METABOLISM, 2017, 70 (04) : 277 - 285
  • [22] Effect of probiotics on obesity-related markers per enterotype: a double-blind, placebo-controlled, randomized clinical trial
    Eun-Ji Song
    Kyungsun Han
    Tae-Joong Lim
    Sanghyun Lim
    Myung-Jun Chung
    Myung Hee Nam
    Hojun Kim
    Young-Do Nam
    EPMA Journal, 2020, 11 : 31 - 51
  • [23] The Effect of Curcumin Supplementation on Pulse Wave Velocity in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
    Alidadi, Mona
    Sahebkar, Amirhossein
    Eslami, Saeid
    Vakilian, Farveh
    Jarahi, Lida
    Alinezhad-Namaghi, Maryam
    Arabi, Seyed Mostafa
    Vakili, Saba
    Tohidinezhad, Fariba
    Nikooiyan, Yasaman
    Norouzy, Abdolreza
    PHARMACOLOGICAL PROPERTIES OF PLANT-DERIVED NATURAL PRODUCTS AND IMPLICATIONS FOR HUMAN HEALTH, 2021, 1308 : 1 - 11
  • [24] Effect of probiotics on obesity-related markers per enterotype: a double-blind, placebo-controlled, randomized clinical trial
    Song, Eun-Ji
    Han, Kyungsun
    Lim, Tae-Joong
    Lim, Sanghyun
    Chung, Myung-Jun
    Nam, Myung Hee
    Kim, Hojun
    Nam, Young-Do
    EPMA JOURNAL, 2020, 11 (01) : 31 - 51
  • [25] Hypoglycemic effect of camel milk powder in type 2 diabetic patients: A randomized, double-blind, placebo-controlled trial
    Zheng, Yajie
    Wu, Fang
    Zhang, Ming
    Fang, Bing
    Zhao, Liang
    Dong, Lijie
    Zhou, Xiaojuan
    Ge, Shaoyang
    FOOD SCIENCE & NUTRITION, 2021, 9 (08): : 4461 - 4472
  • [26] Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial
    Cefalo, Chiara M. A.
    Conte, Caterina
    Sorice, Gian Pio
    Moffa, Simona
    Sun, Vinsin A.
    Cinti, Francesca
    Salomone, Enrica
    Muscogiuri, Giovanna
    Brocchi, Alex A. G.
    Pontecorvi, Alfredo
    Mezza, Teresa
    Giaccari, Andrea
    OBESITY, 2018, 26 (04) : 651 - 657
  • [27] Efficacy of Herbal Supplementation of Purslane Freeze-dried Juice for Weight Loss: An 8-week Randomized, Double-blind, Placebo-controlled Clinical Trial
    Tafti, Mehdi Ajdary
    Moein, Mahmoodreza
    Babajafari, Siavash
    Haem, Elham
    Zarshenas, Mohammad M.
    CURRENT TRADITIONAL MEDICINE, 2024, 10 (01) : 81 - 90
  • [28] Effect of vitamin D supplementation along with weight loss diet on meta-inflammation and fat mass in obese subjects with vitamin D deficiency: A double-blind placebo-controlled randomized clinical trial
    Lotfi-Dizaji, Lida
    Mahboob, Soltanali
    Aliashrafi, Soodabeh
    Vaghef-Mehrabany, Elnaz
    Ebrahimi-Mameghani, Mehrangiz
    Morovati, Ashti
    CLINICAL ENDOCRINOLOGY, 2019, 90 (01) : 94 - 101
  • [29] Bupropion for Overweight Women With Binge-Eating Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    White, Marney A.
    Grilo, Carlos M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (04) : 400 - 406
  • [30] The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: A double-blind, randomized, placebo-controlled trial
    Tek, Cenk
    Palmese, Laura B.
    Krystal, Andrew D.
    Srihari, Vinod H.
    DeGeorge, Pamela C.
    Reutenauer, Erin L.
    Guloksuz, Sinan
    SCHIZOPHRENIA RESEARCH, 2014, 160 (1-3) : 180 - 185